Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 362 (ZNF362) is a protein-coding gene that encodes a predicted DNA-binding transcription factor, primarily enabling sequence-specific binding to cis-regulatory regions targeted by RNA polymerase II[1][2]. ZNF362 acts within the nucleus and is involved in the regulation of gene transcription. Disease associations include various forms of acute leukemia, and gene fusions involving ZNF362 have been observed in the context of B cell precursor acute lymphoblastic leukemia[1][4]. It belongs to the large family of C2H2 zinc finger transcription factors, but there is currently no evidence that ZNF362 is a direct therapeutic target or has clinically significant drug interactions[1][2][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 362 (ZNF362).